← All companies

ENSC

Ensysce Biosciences, Inc.

ENSC Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.43

+0.15 +53.61%

Key statistics

from XBRL data in SEC filings

Market cap

$6.32M

Revenue (TTM)

$4.71M

Net income (TTM)

-$11.8M

EPS (TTM)

$-3.11

P/E ratio

—

Dividend yield

—

Free cash flow

-$7.93M

Cash

$745K

Total assets

$2.17M

Gross margin

—

52-week range

$0.23 – $2.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 15, 2026 8-K Delisting notice or listing-rule failure May 22, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 8, 2026 8-K Director or officer change Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Director or officer change Mar 30, 2026 8-K Amended charter or bylaws Mar 23, 2026 8-K Delisting notice or listing-rule failure Feb 27, 2026 8-K Shareholder vote results Jan 8, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Changed accountants Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Apr 24, 2025 8-K Other events Apr 1, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Entered a material agreement Feb 4, 2025 8-K Amended charter or bylaws Dec 3, 2024 8-K Shareholder vote results Nov 21, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Amended charter or bylaws Oct 18, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 30, 2024 8-K Delisting notice or listing-rule failure Aug 23, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events May 28, 2024 8-K Results of operations (earnings release) May 13, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Other events May 9, 2024 8-K Delisting notice or listing-rule failure Mar 29, 2024